Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-Marketing Study of ADVATE in Hemophilia A Patients in India
NCT04985682Phase 4Completed
- Sponsor
- Takeda
- Start
- Jan 2022
- Primary completion
- Feb 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of recombinant human coagulation factor VIII in hemophilia A, sponsored by Takeda. Started Jan 2022; status: completed.
02
Drugs
recombinant human coagulation factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT04985682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04985682.